In pediatric SLE patients with pulmonary involvement, these IL-17A+ T cells have been postulated to exert direct adverse effects on airway smooth muscle remodeling worsening small airway obstruction [59, 73]. This evidence concerns the gene IL17A and systemic lupus erythematosus.